ibritumomab tiuxetan
90Y-labeled anti-CD20 monoclonal antibody for radioimmunotherapy for patients with relapsed B-cell non-Hodgkin's lymphoma
Ligand Summary
Target Activities
MS4A1
B-lymphocyte antigen CD20
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Kd | 7.85 | ANTIBODY BINDING | ||||